Airway inflammation in children and adolescents with bronchiolitis obliterans

Cytokine

Volumn 73, Issue 1, 2015, Pages 156-162

  Rosewich, Martin ^a   Zissler, Ulrich M ^b   Kheiri, Tanja ^a   Voss, Sandra ^a   Eickmeier, Olaf ^a   Schulze, Johannes ^a   Herrmann, Eva ^a   Dücker, Ruth Pia ^a   Schubert, Ralf ^a   Zielen, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Bronchiolitis obliterans; Paediatric interstitial lung disease; Rare lung diseases; Sputum

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CYTOKINE; MESSENGER RNA; NITRIC OXIDE;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; AGE DISTRIBUTION; AIRWAY REMODELING; ARTICLE; BRONCHIOLITIS OBLITERANS; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NEUTROPHILIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SMALL AIRWAY DISEASE; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; TIFFENEAU INDEX; TRANSCRIPTION REGULATION; UPREGULATION; CASE CONTROL STUDY; CELL COUNT; COMPLICATION; CYTOLOGY; DRUG EFFECTS; EXHALATION; GENETICS; INFLAMMATION; LUNG; METABOLISM; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; SPUTUM; YOUNG ADULT;

ADOLESCENT; BIOMARKERS; BRONCHIOLITIS OBLITERANS; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; CELL COUNT; CHILD; CYTOKINES; EXHALATION; FEMALE; HUMANS; INFLAMMATION; LUNG; MALE; NEUTROPHILS; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS; RNA, MESSENGER; SPUTUM; YOUNG ADULT;

EID: 84924093787     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.10.026     Document Type: Article

References (40)

1. Kurland G., Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol 2005, 39:193-208. 10.1002/ppul.20145.
2. Pichler M., Herrmann G., Schmidt H., Ahrens P., Zielen S. Persistent adenoviral infection and chronic obstructive bronchitis in children: is there a link?. Pediatr Pulmonol 2001, 32:367-371.
3. Smith K.J., Fan L.L. Insights into post-infectious bronchiolitis obliterans in children. Thorax 2006, 61:462-463. 10.1136/thx.2005.052670.
4. Williams K.M., Chien J.W., Gladwin M.T., Pavletic S.Z. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009, 302:306-314. 10.1001/jama.2009.1018.
5. Zhang L., Irion K., Kozakewich H., et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2000, 29:341-350.
6. Kim C.K., Kim S.W., Kim J.S., et al. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest 2001, 120:1101-1106.
7. Moonnumakal S.P., Fan L.L. Bronchiolitis obliterans in children. Curr Opin Pediatr 2008, 20:272-278. 10.1097/MOP.0b013e3282ff62e9.
8. Aguerre V., Castaños C., Pena H.G., Grenoville M., Murtagh P. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol 2010, 45:1180-1185. 10.1002/ppul.21304.
9. Koh Y.Y., Jung D.E., Koh J.Y., Kim J.Y., Yoo Y., Kim C.K. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest 2007, 131:1454-1460. 10.1378/chest.06-0188.
10. Cazzato S., Poletti V., Bernardi F., et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol 2008, 43:381-390. 10.1002/ppul.20784.
11. Kennedy V.E., Todd J.L., Palmer S.M. Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome. Am J Transplant 2013, 13:552-561. 10.1111/ajt.12091.
12. Peterson-Carmichael S.L., Harris W.T., Goel R., et al. Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Pediatr Pulmonol 2009, 44:503-511. 10.1002/ppul.21044.
13. O'Donnell R.A., Peebles C., Ward J.A., et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004, 59:837-842. 10.1136/thx.2003.019349.
14. Myers J.L., Colby T.V. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993, 14:611-622.
15. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 1999;160:p. 2104-17, . doi:10.1164/ajrccm.160.6.ats8-99.
16. Bustin S.A., Benes V., Garson J.A., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622. 10.1373/clinchem.2008.112797.
17. Schulze J., Voss S., Zissler U., Rose M.A., Zielen S., Schubert R. Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge. Respir Res 2012, 13:78. 10.1186/1465-9921-13-78.
18. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262.
19. Eickmeier O., Huebner M., Herrmann E., et al. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine 2010, 50:152-157. 10.1016/j.cyto.2010.02.004.
20. Regamey N., Jeffery P.K., Alton, Eric W.F.W, Bush A., Davies J.C. Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 2011, 66:624-629. 10.1136/thx.2009.134106.
21. Ward C., Pais M., Bish R., et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002, 57:309-316.
22. Ingram J.L., Kraft M. IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies. J Allergy Clin Immunol 2012, 130:829-842. [quiz 843-4]. 10.1016/j.jaci.2012.06.03.
23. de Baets F. Bronchiolitis obliterans in children: a ghostly journey to the origin. Allergol Immunopathol (Madr) 2011, 39:251-252. 10.1016/j.aller.2011.05.003.
24. Madill J., Aghdassi E., Arendt B.M., et al. Oxidative stress and nutritional intakes in lung patients with bronchiolitis obliterans syndrome. Transplant. Proc. 2009, 41:3838-3844. 10.1016/j.transproceed.2009.04.012.
25. Mallol J., Aguirre V., Espinosa V. Increased oxidative stress in children with post infectious Bronchiolitis Obliterans. Allergol Immunopathol (Madr) 2011, 39:253-258. 10.1016/j.aller.2010.09.003.
26. Scholma J., Slebos D.J., Boezen H.M., et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000, 162:2221-2225. 10.1164/ajrccm.162.6.9911104.
27. Elssner A., Vogelmeier C. The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Transpl Infect Dis 2001, 3:168-176.
28. Devouassoux G., Drouet C., Pin I., et al. Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity. Transpl Immunol 2002, 10:303-310.
29. Pease J.E., Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med 2002, 1:19-25.
30. Bérubé J., Bourdon C., Yao Y., Rousseau S. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal 2009, 21:448-456. 10.1016/j.cellsig.2008.12.001.
31. Ali S., Hirschfeld A.F., Mayer M.L., et al. Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia. J Immunol 2013, 190:3949-3958. 10.4049/jimmunol.1201015.
32. Hildebrandt G.C., Granell M., Urbano-Ispizua A., et al. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14:67-74. 10.1016/j.bbmt.2007.09.009.
33. Kimura H., Yoshizumi M., Ishii H., Oishi K., Ryo A. Cytokine production and signaling pathways in respiratory virus infection. Front Microbiol 2013, 4:276. 10.3389/fmicb.2013.00276.
34. Watanabe T., Kitani A., Murray P.J., Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004, 5:800-808. 10.1038/ni1092.
35. Barnes P.J., Dweik R.A., Gelb A.F., et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010, 138:682-692. 10.1378/chest.09-2090.
36. Neurohr C., Huppmann P., Leuschner S., et al. Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2011, 11:129-137. 10.1111/j.1600-6143.2010.03327.x.
37. Antus B., Barta I., Csiszer E. Exhaled nitric oxide in diagnosis of bronchiolitis obliterans syndrome in lung transplant recipients: possible limitations. Am J Transplant 2011, 11:2774-2775. author reply 2776-7. 10.1111/j.1600-6143.2011.03780.x.
38. Wyatt S.E., Nunn P., Hows J.M., et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984, 39:887-894.
39. Barisione G., Bacigalupo A., Crimi E., Brusasco V. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest 2011, 139:633-639. 10.1378/chest.10-1442.
40. Verleden G.M., Vanaudenaerde B.M., Dupont L.J., Van Raemdonck Dirk E. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006, 174:566-570. 10.1164/rccm.200601-071OC.